[go: up one dir, main page]

RU2008142461A - COMBINED MEDICINE FOR TUBERCULOSIS - Google Patents

COMBINED MEDICINE FOR TUBERCULOSIS Download PDF

Info

Publication number
RU2008142461A
RU2008142461A RU2008142461/15A RU2008142461A RU2008142461A RU 2008142461 A RU2008142461 A RU 2008142461A RU 2008142461/15 A RU2008142461/15 A RU 2008142461/15A RU 2008142461 A RU2008142461 A RU 2008142461A RU 2008142461 A RU2008142461 A RU 2008142461A
Authority
RU
Russia
Prior art keywords
tuberculosis
isoniazid
silver nanoparticles
combined medicine
combined
Prior art date
Application number
RU2008142461/15A
Other languages
Russian (ru)
Other versions
RU2403050C2 (en
Inventor
Борис Семенович Кибрик (RU)
Борис Семенович Кибрик
Виталий Маркович Лобановский (RU)
Виталий Маркович Лобановский
Андрей Владимирович Захаров (RU)
Андрей Владимирович Захаров
Ольга Юрьевна Соснина (RU)
Ольга Юрьевна Соснина
Георгий Николаевич Крейцберг (RU)
Георгий Николаевич Крейцберг
Игорь Витальевич Голиков (RU)
Игорь Витальевич Голиков
Иван Витальевич Завойстый (RU)
Иван Витальевич Завойстый
Олег Борисович Уставщиков (RU)
Олег Борисович Уставщиков
Original Assignee
Общество с ограниченной ответственностью "Научно-производственное объединение "Ликом" (RU)
Общество с ограниченной ответственностью "Научно-производственное объединение "Ликом"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "Научно-производственное объединение "Ликом" (RU), Общество с ограниченной ответственностью "Научно-производственное объединение "Ликом" filed Critical Общество с ограниченной ответственностью "Научно-производственное объединение "Ликом" (RU)
Priority to RU2008142461/15A priority Critical patent/RU2403050C2/en
Publication of RU2008142461A publication Critical patent/RU2008142461A/en
Application granted granted Critical
Publication of RU2403050C2 publication Critical patent/RU2403050C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Комбинированный лекарственный препарат, содержащий в качестве активного вещества противотуберкулезный препарат изониазид, отличающийся тем, что он дополнительно содержит компонент потенцирующего действия, в качестве которого применяются наночастицы серебра при следующем соотношении компонентов, г: ! Изониазид 0,001Наночастицы серебра 0,004-0,008 Вода до 1000 A combined drug containing the anti-TB drug isoniazid as an active substance, characterized in that it additionally contains a potentiating component, silver nanoparticles being used in the following ratio, g:! Isoniazid 0.001 Silver nanoparticles 0.004-0.008 Water up to 1000

Claims (1)

Комбинированный лекарственный препарат, содержащий в качестве активного вещества противотуберкулезный препарат изониазид, отличающийся тем, что он дополнительно содержит компонент потенцирующего действия, в качестве которого применяются наночастицы серебра при следующем соотношении компонентов, г:A combined drug containing the anti-tuberculosis drug isoniazid as an active substance, characterized in that it additionally contains a potentiating action component, which is used silver nanoparticles in the following ratio of components, g: ИзониазидIsoniazid 0,0010.001 Наночастицы серебраSilver nanoparticles 0,004-0,0080.004-0.008 ВодаWater до 1000up to 1000
RU2008142461/15A 2008-10-28 2008-10-28 Combined medication of anti-tuberculosis action RU2403050C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2008142461/15A RU2403050C2 (en) 2008-10-28 2008-10-28 Combined medication of anti-tuberculosis action

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2008142461/15A RU2403050C2 (en) 2008-10-28 2008-10-28 Combined medication of anti-tuberculosis action

Publications (2)

Publication Number Publication Date
RU2008142461A true RU2008142461A (en) 2010-05-10
RU2403050C2 RU2403050C2 (en) 2010-11-10

Family

ID=42673309

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008142461/15A RU2403050C2 (en) 2008-10-28 2008-10-28 Combined medication of anti-tuberculosis action

Country Status (1)

Country Link
RU (1) RU2403050C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2452498C2 (en) * 2010-07-20 2012-06-10 Общество с ограниченной ответственностью "Научно-производственное объединение "Ликом" Method for preparing anti-tuberculosis drug

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10159253B2 (en) * 2011-12-21 2018-12-25 Paul Ash Minturn Green biocidal application method for the perfect silver bullet exterminators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2003335C1 (en) * 1991-05-05 1993-11-30 Якутский филиал Научно-практического объединени "Фтизиопульмонологи " Method of treatment for destructive pulmonary tuberculosis accompanied by heavy bacterial expectoration
RU2240806C2 (en) * 2001-11-02 2004-11-27 Дагестанская государственная медицинская академия Method for treating bacillary form of pulmonary tuberculosis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2452498C2 (en) * 2010-07-20 2012-06-10 Общество с ограниченной ответственностью "Научно-производственное объединение "Ликом" Method for preparing anti-tuberculosis drug

Also Published As

Publication number Publication date
RU2403050C2 (en) 2010-11-10

Similar Documents

Publication Publication Date Title
MA38399B2 (en) Formulation in tablet form, useful for treating acute heart failure and chronic heart failure
EA201100032A1 (en) PYRIDINE COMPOUNDS
CO6311007A2 (en) PHARMACEUTICAL COMPOSITION UNDERSTANDING AN AGENT THAT ACTIVATES REGULATORY T-CELLS CD4 + CD25 +, EFFECTIVE AT LOW DOSE
EA201291410A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 4-AMINO-5-FTOR-3- [6- (4-METHILPIPERAZIN-1-IL) -1H-BENZIMIDAZOLE-2-IL] -1H-HINOLIN-2-SHE LOCTOT MONOHYTHA-2-IL] -1H-HINOLIN-2-SH-LYTOTOL-2-IL--1-IL-HYNOLIN-2-SH
MX2013003635A (en) N-heteroaryl compounds.
RU2009116832A (en) COMPOSITION INCLUDING ARBIDOL IN THE COMPOSITION OF PHOSPHOLIPID NANOPARTICLES
BRPI0909211B8 (en) oral tablet-form formulation of tetracycline compounds
ZA202210629B (en) Pharmaceutical composition comprising benzimidazole derivative compound
RU2008142461A (en) COMBINED MEDICINE FOR TUBERCULOSIS
RU2009106499A (en) OPTICAL SINGLE CRYSTAL
MX391191B (en) EXTENDED-RELEASE COMPOSITIONS OF ONAPRISTONE AND METHODS.
RU2008134443A (en) PHARMACOLOGICAL COMPOSITION OF ANTUBERCULOSIS ACTION
RU2013124416A (en) DIINDOLYLMETHANE MEDICINAL PRODUCT AND ITS APPLICATION FOR TREATMENT OF INFLUENZA AND RESPIRATORY VIRAL INFECTIONS
RU2008114796A (en) MULTI-COMPONENT COMBINED COMPOSITION PREVENTING ANTUBERCULOSIS ACTIVITY
RU2013135821A (en) Means for the treatment of purulent-inflammatory processes of soft tissues and mucous membranes
RU2011140993A (en) INSECTICIDAL COMPOSITION
RU2009108917A (en) ORGANIC DRUG
RU2009114003A (en) PREVENTIVE SKIN AGENT WITH ANTITUBERCULOSIS EFFECT
RU2009138724A (en) OINTMENT FOR TREATMENT AND PREVENTION OF ALVEOLITIS
RU2011149491A (en) MEANS FOR LOCAL TREATMENT OF PERIODONTAL DISEASES
AR128434A2 (en) COMPOSITIONS AND METHODS OF TRANSMUCOUS ABSORPTION
CU20160048A7 (en) PHARMACEUTICAL DOSAGE FORMS INCLUDING 1- [6- (MORFOLIN-4-IL) PIRIMIDIN-4-IL] -4- (1H-1,2,3-TRIAZOL-1-IL) -1H-PIRAZOL-5-OLATO OF SODIUM
TR200806302A2 (en) Solubility and stability enhancing pharmaceutical formulation.
RU2011122303A (en) DRUG FOR THE TREATMENT OF ANIMAL HELMINTOSIS
RU2011140991A (en) INSECTICIDAL COMPOSITION

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20120423

PC41 Official registration of the transfer of exclusive right

Effective date: 20130610

MM4A The patent is invalid due to non-payment of fees

Effective date: 20181029